Results of a Phase I clinical trial show that patients who undergo a blood stem cell transplant involving a donor have a lower risk of relapse and lower rates of graft-versus-host disease when they ...

Cyclophosphamide is a generic injectable solution and capsule prescribed to treat conditions such as certain cancers and nephrotic syndrome. The cost of cyclophosphamide, with and without insurance, ...

Please provide your email address to receive an email when new articles are posted on . Week-22 remission rates were 81% among patients using infliximab and 56% in those on cyclophosphamide. Mild to ...

Patients undergoing matched-donor stem cell transplants lived four times longer without episodes of graft-versus-host disease (GVHD) with post-transplant cyclophosphamide-cyclosporin prophylaxis, a ...

PHILADELPHIA -- Rituximab (Rituxan) matched IV cyclophosphamide for improving lung function in patients with interstitial lung disease (ILD) related to systemic sclerosis and other connective tissue ...

Please provide your email address to receive an email when new articles are posted on . New Pan American League of Associations for Rheumatology recommendations include remission maintenance ...

Rituximab and cyclophosphamide are equally effective in achieving remission or low disease activity rates in childhood-onset antineutrophil cytoplasmic antibody–associated vasculitis (AAV), and those ...

Uppsala, Sweden - The risk of bladder cancer rises steadily with increasing cumulative dose of cyclophosphamide in patients with Wegener's granulomatosis (WG), although some of this risk is ...

LINCOLNSHIRE, Ill., May 28, 2025--(BUSINESS WIRE)--Nexus Pharmaceuticals announced that on May 9, 2025, it won a patent litigation involving injectable cyclophosphamide. Cyclophosphamide has been ...

Patients represented three consecutive referrals of children with SDS to the BMT Unit of the Children's Hospital, Hannover Medical University. In all patients, disease-associated mutations in the SBDS ...